Small artery mechanics in hyperhomocysteinemic mice: Effects of angiostensin II

Journal of Hypertension

Volumn 22, Issue 5, 2004, Pages 959-966

  Neves, Mario F ^a   Endemann, Dierk ^a   Amiri, Farhad ^a   Virdis, Agostino ^a   Pu, Qian ^a   Rozen, Rima ^b   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cardiovascular risk; Elastin collagen; Homocysteine; Hypertension; Mouse; Resistance arteries; Vascular mechanics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANGIOTENSIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ELASTIN; HOMOCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY; ARTERY MEDIA; ARTICLE; BLOOD VESSEL WALL; COMPARATIVE STUDY; CONTROLLED STUDY; HETEROZYGOTE; HYPERHOMOCYSTEINEMIA; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOUSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RIGIDITY; STRESS STRAIN RELATIONSHIP; WILD TYPE; YOUNG MODULUS;

EID: 2542496224     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200405000-00018     Document Type: Article

References (29)

1. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338:1042-1050.
2. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131:363-375.
3. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats. Effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999; 100:2267-2275.
4. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340:115-126.
5. Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43:414-421.
6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113.
7. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001; 10:433-443.
8. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension. Hypertension 2000; 36:312-318.
9. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52:639-672.
10. Laurant P, Touyz RM, Schiffrin EL. Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res 1997; 34:117-125.
11. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension. Dual process of remodeling and growth. Hypertension 1993; 21:391-397.
12. Pu Q, Touyz RM, Schiffrin EL. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 2002; 20:899-907.
13. Durand P, Fortin LJ, Lussier-Cacan S, Davignon J, Blache D. Hyperhomocysteinemia induced by folic acid deficiency and methionine load - applications of a modified HPLC method. Clin Chim Acta 1996; 252:83-93.
14. Tsai MY, Arnett DK, Eckfeldt JH, Williams RR, Ellison RC. Plasma homocysteine and its association with carotid intimal-mediai wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study. Atherosclerosis 2000; 151:519-524.
15. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999; 99:2383-2388.
16. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91:6369-6373.
17. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58:731-741.
18. Smilde TJ, van den Berkmortel FW, Boers GH, Wollersheim H, de Boo T, van Langen H, et al. Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1998; 18:1958-1963.
19. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18:535-541.
20. Bortolotto LA, Safar ME, Billaud E, Lacroix C, Asmar R, London GM, et al. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999; 34:837-842.
21. Charpiot P, Bescond A, Augier T, Chareyre C, Fraterno M, Rolland PH, et al. Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril- hydrochlorothiazide. Matrix Biol 1998; 17:559-574.
22. Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease: enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997; 17:2074-2081.
23. Zhou J, Moller J, Danielsen CC, Bentzon J, Ravn HB, Austin RC, et al. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21:1470-1476.
24. Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 2002; 39:443-448.
25. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001; 107:675-683.
26. Majors AK, Sengupta S, Willard B, Kinter MT, Pyeritz RE, Jacobsen DW. Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler Thromb Vasc Biol 2002; 22:1354-1359.
27. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277:1775-1781.
28. Sutton-Tyrrell K, Bostom A, Selhub J, Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 1997; 96:1745-1749.
29. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94:2410-2416.